Last update:

Ophthalmology news

FDA approves combination Yuvezzi eye drop for presbyopia in adults

The U.S. Food and Drug Administration has approved Yuvezzi (carbachol and brimonidine tartrate) ophthalmic solution 2.75%/0.1%, previously known as Brimochol PF, as the first and only dual-agent eye drop for the treatment ...

Eye movements help the brain see in 3D: Research challenges long-standing assumption

When you go for a walk, how does your brain know the difference between a parked car and a moving car? This seemingly simple distinction is challenging because eye movements, such as the ones we make when watching a car pass ...

Decoding the molecular signatures of night blindness

Congenital stationary night blindness (CSNB) is caused by mutations in a specific calcium channel. A comprehensive proteomic study by researchers at the University of Innsbruck now reveals how these mutations trigger complex, ...

Eye drops may affect liver cells

A chemical used in some over-the-counter eye drops may affect liver cells and be transformed to a PFAS-like substance. This is according to a new study from Örebro University published in Environment International. "We initiated ...

New approach offers hope for people with rare eye cancer

Researchers at Queen Mary's Barts Cancer Institute have found a more active approach to monitoring and treating people with a rare eye cancer (known as uveal melanoma) that has spread to the liver could help some patients ...